Intellia Therapeutics, Inc. (NTLA)
12.55
-0.29
(-2.26%)
USD |
NASDAQ |
Aug 24, 16:00
12.55
0.00 (0.00%)
After-Hours: 20:00
Intellia Therapeutics Enterprise Value : 1.433B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.433B |
| August 20, 2026 | 1.377B |
| August 19, 2026 | 1.495B |
| August 18, 2026 | 1.260B |
| August 17, 2026 | 1.328B |
| August 14, 2026 | 1.303B |
| August 13, 2026 | 1.292B |
| August 12, 2026 | 1.328B |
| August 11, 2026 | 1.319B |
| August 10, 2026 | 1.319B |
| August 07, 2026 | 1.307B |
| August 06, 2026 | 1.209B |
| August 05, 2026 | 1.172B |
| August 04, 2026 | 1.221B |
| August 03, 2026 | 1.144B |
| July 31, 2026 | 1.131B |
| July 30, 2026 | 1.188B |
| July 29, 2026 | 1.148B |
| July 28, 2026 | 1.160B |
| July 27, 2026 | 1.130B |
| July 24, 2026 | 1.138B |
| July 23, 2026 | 1.190B |
| July 22, 2026 | 1.194B |
| July 21, 2026 | 1.242B |
| July 20, 2026 | 1.165B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.228B |
| July 16, 2026 | 1.296B |
| July 15, 2026 | 1.461B |
| July 14, 2026 | 1.498B |
| July 13, 2026 | 1.459B |
| July 10, 2026 | 1.626B |
| July 09, 2026 | 1.798B |
| July 08, 2026 | 1.994B |
| July 07, 2026 | 2.076B |
| July 06, 2026 | 2.134B |
| July 02, 2026 | 2.094B |
| July 01, 2026 | 2.050B |
| June 30, 2026 | 2.005B |
| June 29, 2026 | 1.705B |
| June 26, 2026 | 1.714B |
| June 25, 2026 | 1.635B |
| June 24, 2026 | 1.571B |
| June 23, 2026 | 1.541B |
| June 22, 2026 | 1.602B |
| June 18, 2026 | 1.592B |
| June 17, 2026 | 1.535B |
| June 16, 2026 | 1.457B |
| June 15, 2026 | 1.502B |
| June 12, 2026 | 1.163B |
| June 11, 2026 | 1.192B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Beam Therapeutics, Inc. | 2.168B |
| Twist Bioscience Corp. | 9.051B |
| Tenaya Therapeutics, Inc. | 82.22M |
| Moderna, Inc. | 54.06B |
| Arrowhead Pharmaceuticals, Inc. | 12.07B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -106.63M |
| Revenue (Quarterly) | 7.659M |
| Total Expenses (Quarterly) | 114.29M |
| EPS Diluted (Quarterly) | -0.7989 |
| Gross Profit Margin (Quarterly) | 72.58% |
| Profit Margin (Quarterly) | -1.39K% |
| Earnings Yield | -26.75% |
| Normalized Earnings Yield | -26.72 |